Cargando…

Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci

BACKGROUND: Enterococci are the third leading cause of nosocomial bloodstream infection (BSI). Vancomycin resistant enterococci are common and provide treatment challenges; however questions remain about VRE's pathogenicity and its direct clinical impact. This study analyzed the inflammatory re...

Descripción completa

Detalles Bibliográficos
Autores principales: Bar, Katharine, Wisplinghoff, Hilmar, Wenzel, Richard P, Bearman, Gonzalo ML, Edmond, Michael B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592497/
https://www.ncbi.nlm.nih.gov/pubmed/17002792
http://dx.doi.org/10.1186/1471-2334-6-145
_version_ 1782130407754432512
author Bar, Katharine
Wisplinghoff, Hilmar
Wenzel, Richard P
Bearman, Gonzalo ML
Edmond, Michael B
author_facet Bar, Katharine
Wisplinghoff, Hilmar
Wenzel, Richard P
Bearman, Gonzalo ML
Edmond, Michael B
author_sort Bar, Katharine
collection PubMed
description BACKGROUND: Enterococci are the third leading cause of nosocomial bloodstream infection (BSI). Vancomycin resistant enterococci are common and provide treatment challenges; however questions remain about VRE's pathogenicity and its direct clinical impact. This study analyzed the inflammatory response of Enterococcal BSI, contrasting infections from vancomycin-resistant and vancomycin-susceptible isolates. METHODS: We performed a historical cohort study on 50 adults with enterococcal BSI to evaluate the associated systemic inflammatory response syndrome (SIRS) and mortality. We examined SIRS scores 2 days prior through 14 days after the first positive blood culture. Vancomycin resistant (n = 17) and susceptible infections (n = 33) were compared. Variables significant in univariate analysis were entered into a logistic regression model to determine the affect on mortality. RESULTS: 60% of BSI were caused by E. faecalis and 34% by E. faecium. 34% of the isolates were vancomycin resistant. Mean APACHE II (A2) score on the day of BSI was 16. Appropriate antimicrobials were begun within 24 hours in 52%. Septic shock occurred in 62% and severe sepsis in an additional 18%. Incidence of organ failure was as follows: respiratory 42%, renal 48%, hematologic 44%, hepatic 26%. Crude mortality was 48%. Progression to septic shock was associated with death (OR 14.9, p < .001). There was no difference in A2 scores on days -2, -1 and 0 between the VRE and VSE groups. Maximal SIR (severe sepsis, septic shock or death) was seen on day 2 for VSE BSI vs. day 8 for VRE. No significant difference was noted in the incidence of organ failure, 7-day or overall mortality between the two groups. Univariate analysis revealed that AP2>18 at BSI onset, and respiratory, cardiovascular, renal, hematologic and hepatic failure were associated with death, but time to appropriate therapy >24 hours, age, and infection due to VRE were not. Multivariate analysis revealed that hematologic (OR 8.4, p = .025) and cardiovascular failure (OR 7.5, p = 032) independently predicted death. CONCLUSION: In patients with enterococcal BSI, (1) the incidence of septic shock and organ failure is high, (2) patients with VRE BSI are not more acutely ill prior to infection than those with VSE BSI, and (3) the development of hematologic or cardiovascular failure independently predicts death.
format Text
id pubmed-1592497
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15924972006-10-07 Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci Bar, Katharine Wisplinghoff, Hilmar Wenzel, Richard P Bearman, Gonzalo ML Edmond, Michael B BMC Infect Dis Research Article BACKGROUND: Enterococci are the third leading cause of nosocomial bloodstream infection (BSI). Vancomycin resistant enterococci are common and provide treatment challenges; however questions remain about VRE's pathogenicity and its direct clinical impact. This study analyzed the inflammatory response of Enterococcal BSI, contrasting infections from vancomycin-resistant and vancomycin-susceptible isolates. METHODS: We performed a historical cohort study on 50 adults with enterococcal BSI to evaluate the associated systemic inflammatory response syndrome (SIRS) and mortality. We examined SIRS scores 2 days prior through 14 days after the first positive blood culture. Vancomycin resistant (n = 17) and susceptible infections (n = 33) were compared. Variables significant in univariate analysis were entered into a logistic regression model to determine the affect on mortality. RESULTS: 60% of BSI were caused by E. faecalis and 34% by E. faecium. 34% of the isolates were vancomycin resistant. Mean APACHE II (A2) score on the day of BSI was 16. Appropriate antimicrobials were begun within 24 hours in 52%. Septic shock occurred in 62% and severe sepsis in an additional 18%. Incidence of organ failure was as follows: respiratory 42%, renal 48%, hematologic 44%, hepatic 26%. Crude mortality was 48%. Progression to septic shock was associated with death (OR 14.9, p < .001). There was no difference in A2 scores on days -2, -1 and 0 between the VRE and VSE groups. Maximal SIR (severe sepsis, septic shock or death) was seen on day 2 for VSE BSI vs. day 8 for VRE. No significant difference was noted in the incidence of organ failure, 7-day or overall mortality between the two groups. Univariate analysis revealed that AP2>18 at BSI onset, and respiratory, cardiovascular, renal, hematologic and hepatic failure were associated with death, but time to appropriate therapy >24 hours, age, and infection due to VRE were not. Multivariate analysis revealed that hematologic (OR 8.4, p = .025) and cardiovascular failure (OR 7.5, p = 032) independently predicted death. CONCLUSION: In patients with enterococcal BSI, (1) the incidence of septic shock and organ failure is high, (2) patients with VRE BSI are not more acutely ill prior to infection than those with VSE BSI, and (3) the development of hematologic or cardiovascular failure independently predicts death. BioMed Central 2006-09-26 /pmc/articles/PMC1592497/ /pubmed/17002792 http://dx.doi.org/10.1186/1471-2334-6-145 Text en Copyright © 2006 Bar et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bar, Katharine
Wisplinghoff, Hilmar
Wenzel, Richard P
Bearman, Gonzalo ML
Edmond, Michael B
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci
title Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci
title_full Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci
title_fullStr Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci
title_full_unstemmed Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci
title_short Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci
title_sort systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592497/
https://www.ncbi.nlm.nih.gov/pubmed/17002792
http://dx.doi.org/10.1186/1471-2334-6-145
work_keys_str_mv AT barkatharine systemicinflammatoryresponsesyndromeinadultpatientswithnosocomialbloodstreaminfectionsduetoenterococci
AT wisplinghoffhilmar systemicinflammatoryresponsesyndromeinadultpatientswithnosocomialbloodstreaminfectionsduetoenterococci
AT wenzelrichardp systemicinflammatoryresponsesyndromeinadultpatientswithnosocomialbloodstreaminfectionsduetoenterococci
AT bearmangonzaloml systemicinflammatoryresponsesyndromeinadultpatientswithnosocomialbloodstreaminfectionsduetoenterococci
AT edmondmichaelb systemicinflammatoryresponsesyndromeinadultpatientswithnosocomialbloodstreaminfectionsduetoenterococci